Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aging01:26

Aging

801
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
801
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

3.6K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.6K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

713
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

264
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
264

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefits and Barriers to Use of Continuous Glucose Monitoring 24 Weeks Following Hospital Discharge.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes.

Journal of the Endocrine Society·2025
Same author

Anabolic-androgenic steroids among recreational athletes and cardiovascular risk.

Current opinion in cardiology·2025
Same author

A Smooth Transition.

The New England journal of medicine·2025
Same author

The desire for parenthood and biological children among adult transgender and gender-diverse individuals seeking gender-affirming care.

American journal of obstetrics and gynecology·2025
Same author

Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy.

Transgender health·2024

Related Experiment Video

Updated: Feb 11, 2026

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
11:57

Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

Published on: November 26, 2017

9.2K

GONADOPENIA AND AGING IN MEN.

Sandeep Singh Dhindsa, Michael S Irwig, Kathleen Wyne

    Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
    |April 17, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Aging men may experience decreased testosterone levels, impacting health and requiring careful assessment. Testosterone therapy offers modest benefits for symptomatic individuals, but risks and comorbidities must be considered.

    More Related Videos

    Continuous High-resolution Microscopic Observation of Replicative Aging in Budding Yeast
    10:41

    Continuous High-resolution Microscopic Observation of Replicative Aging in Budding Yeast

    Published on: August 20, 2013

    13.3K
    Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
    09:10

    Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

    Published on: January 30, 2026

    296

    Related Experiment Videos

    Last Updated: Feb 11, 2026

    Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
    11:57

    Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans

    Published on: November 26, 2017

    9.2K
    Continuous High-resolution Microscopic Observation of Replicative Aging in Budding Yeast
    10:41

    Continuous High-resolution Microscopic Observation of Replicative Aging in Budding Yeast

    Published on: August 20, 2013

    13.3K
    Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging
    09:10

    Measuring Single-Cell Aging with an Imaging-based Biomarker of Chromatin and Epigenetic Aging

    Published on: January 30, 2026

    296

    Area of Science:

    • Geriatric Endocrinology
    • Men's Health
    • Hormone Replacement Therapy

    Background:

    • Testosterone decline with aging is a growing clinical concern due to the aging population and interest in testosterone therapy.
    • Comprehensive evaluation is crucial for assessing testosterone deficiency and managing treatment risks versus benefits in older men.

    Purpose of the Study:

    • To review key issues for clinical decision-making regarding testosterone deficiency in aging men.
    • To guide interpretation of test results, differential diagnosis, and therapeutic options.

    Main Methods:

    • Literature review using PubMed searches.

    Main Results:

    • Assessing testosterone in geriatric males requires understanding assay limitations, symptoms, comorbidity impacts, and therapy risks.
    • Realistic expectations for testosterone replacement therapy benefits are essential for successful treatment.

    Conclusions:

    • Low testosterone prevalence increases with age, with obesity and diabetes potentially influencing levels.
    • Clinical trials show modest benefits of testosterone treatment for symptomatic low testosterone.
    • Geriatric male assessment should integrate testosterone levels with functional status and comorbidities.